854382-06-2 Usage
General Description
2-(pyridin-4-ylmethylamino)nicotinic acid is a chemical compound with the molecular formula C13H14N2O2. It is a derivative of niacin, also known as vitamin B3, and contains a pyridine ring. 2-(pyridin-4-ylmethylamino)nicotinic acid has potential applications in pharmaceuticals and as a building block for the synthesis of novel organic molecules. It may also exhibit various biological activities, making it a subject of interest for scientific research and drug development. However, further studies are needed to fully understand the properties and potential uses of 2-(pyridin-4-ylmethylamino)nicotinic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 854382-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,4,3,8 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 854382-06:
(8*8)+(7*5)+(6*4)+(5*3)+(4*8)+(3*2)+(2*0)+(1*6)=182
182 % 10 = 2
So 854382-06-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H11N3O2/c16-12(17)10-2-1-5-14-11(10)15-8-9-3-6-13-7-4-9/h1-7H,8H2,(H,14,15)(H,16,17)
854382-06-2Relevant articles and documents
Towards new sila- Or germa-derivatives of motesanib
Boddaert, Thomas,Querolle, Olivier,Meerpoel, Lieven,Angibaud, Patrick,Maddaluno, Jacques,Durandetti, Muriel
, p. 1210 - 1218 (2019/07/31)
– Developing new access to original silylated heterocycles is an emerging challenge in medicinal chemistry. In this paper, we describe a synthesis of silylated and germylated Motesanib analogues relying on a peptide coupling between a nicotinic acid derivative and silylated or germylated heterocycles, prepared according to our previous reports.
2 - aminomethyl pyridine-based nicotinamide compound and its preparation method and application (by machine translation)
-
Paragraph 0082-0086, (2017/08/28)
The invention relates to the general formula (I) compounds and salts thereof, such compounds have a strong reverse tumor multi-drug resistance (MDR) function, activity is far higher than the veraparnil, and has a small cell toxicity, the invention also re
